by Elizabeth Story, MD | Oct 21, 2025 | Blog
GLP-1 receptor agonists like semaglutide and tirzepatide have revolutionized weight loss and diabetes care. But a growing number of patients and clinicians are exploring microdosing—taking a fraction of the standard dose—to unlock broader health benefits with fewer...
by Elizabeth Story, MD | Jul 15, 2025 | Blog
If you follow my posts on social media, you already know that I encourage my patients to research the benefits of weight loss “drugs.” Although they can be controversial, the evidence is mounting in terms of the ground-breaking solution these medications provide for...
by Elizabeth Story, MD | May 8, 2024 | News
There are so many questions brought about by the news media in regards to health. And now so many are related to the GLP-1 medications such as Ozempic and Mounjaro. One of the focuses of the regular blog will be to address much of the confusion and questions generated...
by Elizabeth Story, MD | Nov 30, 2022 | News
Eat better. Exercise more. Get your steps in. Create a caloric deficit. Sometimes we don’t have the time or the mental fortitude to do the things we know we need to do to lose weight and get or stay fit. Especially as we age or experience major life changes. Have you...
